13 hours ago We use cookies to allow our site to work properly. Data may be shared with our partners as explained in “Cookie policy” and “Privacy Policy”. >> Go To The Portal
IQVIA is committed to protecting your privacy. This Platform is provided by IQVIA for the purposes of supporting your participation in a clinical trial, either as a patient or as a member of the study team (PI, Patient Guide, Study Concierge, etc.).
Virtual trials promise to transform the way clinical research is conducted. This model delivers multiple benefits including access to larger patient populations, easier recruiting, more and better data collection, lower levels of attrition, and ultimately lower costs.
If you wish to access, correct, update or request removal of any of your information you provided to us or if you have any questions regarding this Privacy Policy or would like more information on our privacy practices, please contact us at: StudyHub-Support@IQVIA.com.
The ease of use of live face-to-face virtual meeting tools means PIs can meet with patients more frequently than they might in a traditional trial, and can quickly connect with patients if they have additional questions or are dealing with side effects. What if the patient needs help with a treatment?
When you participate in a clinical trial (or evaluate whether to participate in a clinical trial), you will be provided with information about the trial itself and how information about you will be used in connection with the trial.
We collect personally identifiable information from you (for example, your first name, last name, title and/or email address, contact telephone number (s) and zip or postal code that you provide to us through your use of the Platform including in any of the ways explained below (“personally identifiable information”), personal health information, financial information, and academic education and professional information through direct user input as described below. We may also receive information about how you use our website through the automatic operation of “cookies” and web logs and other technologies.
When you participate in a clinical trial (or evaluate whether to participate in a clinical trial), you will be provided with information about the trial itself and how information about you will be used in connection with the trial. This “Informed Consent” form will govern how your personal information is used. This privacy policy only applies to information that is obtained through this Platform beyond the information that is collected and used for the clinical trial. The ICF will be incorporated, but not merged, into this Privacy Policy. Each ICF will include, as appropriate, the scope of the study, time line and privacy information that you agree to allow the Site personnel, IQVIA, and others involved in the study process, to collect and share and to whom that information can be shared. To the extent any terms or provisions of an ICF conflict with the terms and provisions of this Privacy Policy, the terms and conditions of the ICF shall control.
Information collected about your mobile device and internet connection may include the device's unique device identifier, IMEI number, IP address, operating system, browser type, browser language, referring/exit pages and URLs, mobile network information and the device's telephone number. Tools, applications, and widgets that we enable you to download to enable you to use the services on any mobile devices, may store information on your mobile or other devices. These tools may transmit personal information to us to enable you to access your user account and to enable us to track use of these tools. Some of these tools may enable you to email reports and other information from the tool. We may use personal or non-identifiable information transmitted to us to enhance these tools, to develop new tools, for quality improvement and as otherwise described in this Privacy Policy or in other notices we provide. We may send you e-mail messages with a “click-through URL” linked to the content of our Platform. When you click onto one of these URLs, you will pass through our server before arriving at the destination webpage. We may track this click-through data to help us determine your interest in the subject matter and measure the effectiveness of our user communications. You can avoid being tracked simply by not clicking on any links or images in e-mail we send you.
You can always choose not to provide information, however, if you choose not to provide information, you will not be able to use any of the services that require you to log-in and you may be unable to participate in the relevant clinical trial.
The traditional approach to research frequently means customers experience slow patient recruitment, delaying start-up. High dropout rates due to travel and onerous scheduling requirements. Long-term safety studies requiring years of follow-up. IQVIA Virtual Research Solutions offer an alternative.
We design and execute clinical trials and late-phase studies with people in mind. By bringing virtual trials and real world evidence-based virtual studies directly to patients at home, we vastly expand our recruiting range and retention rates - including the ability to reach diverse populations and difficult-to-recruit candidates.
Avoid costly delays, increase data quality and operational efficiency and meet compliance requirements. IQVIA Virtual Research Solutions employ
There are several virtual trials already under way in the US with regulatory approval, and regulators across the EU are currently examining these models for use beginning in 2019. Overall, our experience has been that regulators are increasingly interested in the use of digital technology and connected devices to improve clinical research.
The technology-enabled nature of virtual trials makes them as safe as, and in some cases, safer than traditional trial environments. The use of telemedicine means patients often have more interaction with PIs, and can schedule additional calls if they have concerns or experience side effects.